Toward health system strengthening in low- and middle-income countries: insights from mathematical modeling of drug supply chains
Open Access
- 24 August 2020
- journal article
- research article
- Published by Springer Nature in BMC Health Services Research
- Vol. 20 (1) , 1-12
Abstract
Background: Global health priority setting increasingly focuses on understanding the functioning of health systems and on how they can be strengthened. Beyond vertical programs, health systems research should examine system-wide delivery platforms (e.g. health facilities) and operational elements (e.g. supply chains) as primary units of study and evaluation. Methods: We use dynamical system methods to develop a simple analytical model for the supply chain of a low-income country’s health system. In doing so, we emphasize the dynamic links that integrate the supply chain within other elements of the health system; and we examine how the evolution over time of such connections would affect drug delivery, following the implementation of selected interventions (e.g. enhancing road networks, expanding workforce). We also test feedback loops and forecasts to study the potential impact of setting up a digital system for tracking drug delivery to prevent drug stockout and expiration. Results: Numerical simulations that capture a range of supply chain scenarios demonstrate the impact of different health system strengthening interventions on drug stock levels within health facilities. Our mathematical modeling also points to how implementing a digital drug tracking system could help anticipate and prevent drug stockout and expiration. Conclusion: Our mathematical model of drug supply chain delivery represents an important component toward the development of comprehensive quantitative frameworks that aim at describing health systems as complex dynamical systems. Such models can help predict how investments in system-wide interventions, like strengthening drug supply chains in low-income settings, may improve population health outcomes.Keywords
Funding Information
- Bill and Melinda Gates Foundation (INV-010174)
This publication has 17 references indexed in Scilit:
- Availability and affordability of essential medicines for diabetes across high-income, middle-income, and low-income countries: a prospective epidemiological studyThe Lancet Diabetes & Endocrinology, 2018
- Baseline assessment of WHO’s target for both availability and affordability of essential medicines to treat non-communicable diseasesPLOS ONE, 2017
- The Impact of Inventory Management on Stock-Outs of Essential Drugs in Sub-Saharan Africa: Secondary Analysis of a Field Experiment in ZambiaPLOS ONE, 2016
- Availability and affordability of essential medicines for children in the Western part of Ethiopia: implication for accessBMC Pediatrics, 2016
- Health Product Supply Chains in Developing Countries: Diagnosis of the Root Causes of Underperformance and an Agenda for ReformHealth Systems & Reform, 2015
- The benefits of redesigning Benin's vaccine supply chainVaccine, 2014
- Measuring Access to Medicines: A Survey of Prices, Availability and Affordability in Shaanxi Province of ChinaPLOS ONE, 2013
- Availability, prices and affordability of the World Health Organization’s essential medicines for children in GuatemalaGlobalization and Health, 2012
- Impact of Drug Stock-Outs on Death and Retention to Care among HIV-Infected Patients on Combination Antiretroviral Therapy in Abidjan, Côte d'IvoirePLOS ONE, 2010
- Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysisThe Lancet, 2009